1-5 of 5
Philipp Erben
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

An Empirical Survey on the Adaption of Neoadjuvant Chemotherapy in Bladder Cancer

Available to Purchase
Subject Area:
Further Areas
Moritz J. Reike, Alina Reicherz, Karl H. Tully, Henning Bahlburg, Moritz Maas, Peter Bach, Niklas Klümper, Markus Eckstein, Arndt Hartmann, Johannes Breyer, Philipp Erben, Christian Bolenz, Joachim Noldus, Sebastian Berg, Florian Roghmann
Journal: Urologia Internationalis
Urol Int (2024) 108 (3): 183–189.
https://doi.org/10.1159/000536321
Published Online: 19 January 2024
View article titled, An Empirical Survey on the Adaption of Neoadjuvant Chemotherapy in Bladder Cancer
Open the PDF for An Empirical Survey on the Adaption of Neoadjuvant Chemotherapy in Bladder Cancer in another window
Journal Articles

Upper Tract Urinary Cancer Recurrence after Radical Cystectomy: Risk Assessment of Intraoperative Frozen Section

Available to Purchase
Subject Area:
Further Areas
Malin Nientiedt, Frank Waldbillig, Felix Stroop, Philipp Nuhn, Philipp Erben, Zoran V. Popovic, Cleo-Aron Weis, Maurice Stephan Michel, Maximilian C. Kriegmair
Journal: Urologia Internationalis
Urol Int (2022) 106 (8): 816–824.
https://doi.org/10.1159/000521804
Published Online: 04 February 2022
View article titled, Upper Tract Urinary Cancer Recurrence after Radical Cystectomy: Risk Assessment of Intraoperative Frozen Section
Open the PDF for Upper Tract Urinary Cancer Recurrence after Radical Cystectomy: Risk Assessment of Intraoperative Frozen Section in another window
Journal Articles

Impact of Altered WNT2B Expression on Bladder Wall Fibroblasts: Implications for Apoptosis Regulation in the Stroma of the Lower Urinary Tract

Available to Purchase
Subject Area:
Further Areas
Thomas Stefan Worst, Kristina Daskalova, Annette Steidler, Karin Berner-Leischner, Ralph Röth, Beate Niesler, Maximilian C. Kriegmair, Philipp Erben, Daniel Pfalzgraf
Journal: Urologia Internationalis
Urol Int (2017) 99 (4): 476–483.
https://doi.org/10.1159/000481440
Published Online: 31 October 2017
View article titled, Impact of Altered WNT2B Expression on Bladder Wall Fibroblasts: Implications for Apoptosis Regulation in the Stroma of the Lower Urinary Tract
Open the PDF for Impact of Altered WNT2B Expression on Bladder Wall Fibroblasts: Implications for Apoptosis Regulation in the Stroma of the Lower Urinary Tract in another window
Journal Articles

ERBB2 Expression as Potential Risk-Stratification for Early Cystectomy in Patients with pT1 Bladder Cancer and Concomitant Carcinoma in situ

Available to Purchase
Subject Area:
Further Areas
Johannes Breyer, Wolfgang Otto, Ralph M. Wirtz, Bernd Wullich, Bastian Keck, Philipp Erben, Maximilian C. Kriegmair, Robert Stoehr, Markus Eckstein, Mark Laible, Kornelia Schlombs, Sebastian Eidt, Stefan Denzinger, Maximilian Burger, Arndt Hartmann, on behalf of the BRIDGE Consortium
Journal: Urologia Internationalis
Urol Int (2017) 98 (3): 282–289.
https://doi.org/10.1159/000453670
Published Online: 17 December 2016
View article titled, ERBB2 Expression as Potential Risk-Stratification for Early Cystectomy in Patients with pT1 Bladder Cancer and Concomitant Carcinoma in situ
Open the PDF for ERBB2 Expression as Potential Risk-Stratification for Early Cystectomy in Patients with pT1 Bladder Cancer and Concomitant Carcinoma in situ in another window
Journal Articles

Complete and Durable Remission of Human Epidermal Growth Factor Receptor 2-Positive Metastatic Urothelial Carcinoma Following Third-Line Treatment with Trastuzumab and Gemcitabine

Available to Purchase
Subject Area:
Further Areas
Felix Wezel, Philipp Erben, Timo Gaiser, Johannes Budjan, Jost von Hardenberg, Maurice Stephan Michel, Christian Bolenz
Journal: Urologia Internationalis
Urol Int (2018) 100 (1): 122–125.
https://doi.org/10.1159/000443280
Published Online: 19 January 2016
View article titled, Complete and Durable Remission of Human Epidermal Growth Factor Receptor 2-Positive Metastatic Urothelial Carcinoma Following Third-Line Treatment with Trastuzumab and Gemcitabine
Open the PDF for Complete and Durable Remission of Human Epidermal Growth Factor Receptor 2-Positive Metastatic Urothelial Carcinoma Following Third-Line Treatment with Trastuzumab and Gemcitabine in another window